Sign in

    Laura Li • Deutsche Bank

    Laura Li's questions to Blade Air Mobility Inc (BLDE) leadership

    Laura Li's questions to Blade Air Mobility Inc (BLDE) leadership • Q2 2025

    Question

    Laura Li of Deutsche Bank inquired about Blade's capital allocation priorities for the proceeds from the Joby transaction, the company's confidence in achieving the $35 million in milestone-based payments, and any potential operational impacts of the divestiture on the remaining medical business.

    Answer

    CEO Rob Wiesenthal stated that the capital will be deployed for actionable M&A opportunities to scale the medical business and expressed confidence in achieving the transaction milestones. CFO Will Hayburn clarified that the milestones are tied to executive retention and status-quo financial performance. Both executives affirmed the medical business is well-positioned for success, highlighting a new long-term partnership with Joby for eVTOL access which they see as a competitive advantage.

    Ask Fintool Equity Research AI

    Laura Li's questions to EHang Holdings Ltd (EH) leadership

    Laura Li's questions to EHang Holdings Ltd (EH) leadership • Q1 2025

    Question

    Laura Li from Deutsche Bank asked about EHang's competitive strategy against peers with different eVTOL designs, such as tiltrotor models, that may receive Type Certification sooner than EHang's VT-35.

    Answer

    An EHang executive explained that urban and intercity markets have distinct needs, positioning the compact, cost-effective EH-216S against ground transport, not other eVTOLs. They highlighted the EH-216S's smaller footprint, lower infrastructure needs, and superior economics due to autonomous flight. The company plans to compete in the long-range market with its upcoming VT-35, which is expected to have a price advantage.

    Ask Fintool Equity Research AI